ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma
2022 · Cell Death Discovery · 93 citations
https://doi.org/10.1038/s41420-022-01286-w
H
Huangyi Ji
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
176
Citations
4
h-index
2
i10-index
Huangyi Ji is an academic researcher from Jilin Agricultural University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Glioma Diagnosis and Treatment & Microbial bioremediation and biosurfactants. The author has an h-index of 4, co-authored 6 publications.
Papers by this author
worksExosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas
2021 · Molecular Therapy — Oncolytics · 69 citations
https://doi.org/10.1016/j.omto.2021.08.004
IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
2024 · Journal of Translational Medicine · 6 citations
https://doi.org/10.1186/s12967-024-05755-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat